av/revolution-medicines--big.svg

COM:REVMED

Revolution Medicines

  • Stock

USD

Last Close

56.78

22/11 21:00

Market Cap

7.01B

Beta: -

Volume Today

1.17M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-31.13M
-
-41.79M
34.25%
-47.66M
14.06%
-108.16M
126.92%
-187.09M
72.98%
-248.71M
32.93%
-436.37M
75.46%
depreciation and amortization
1.19M
-
1.76M
48.48%
3.34M
89.46%
6.54M
95.84%
7.33M
12.02%
9.66M
31.70%
9.31M
3.59%
deferred income tax
201K
-
-4.37M
2,275.62%
-375K
91.42%
-419K
-
-3.91M
833.17%
stock based compensation
141K
-
855K
506.38%
3.16M
269.71%
8.89M
181.11%
20.72M
133.22%
31.20M
50.53%
61.77M
98.01%
change in working capital
4.65M
-
38.06M
718.52%
-8.83M
123.19%
-8.30M
5.94%
8.72M
205.06%
-13.49M
254.62%
40.66M
401.45%
accounts receivables
-1.43M
-
2.34M
263.46%
464K
80.20%
1.26M
170.69%
3.42M
172.21%
inventory
1.43M
-
-2.34M
263.46%
7.68M
427.73%
accounts payables
1.97M
-
109K
94.46%
5.26M
4,729.36%
305K
94.21%
2.24M
634.10%
7.29M
225.50%
32.47M
345.51%
other working capital
2.68M
-
37.95M
1,315.06%
-14.09M
137.13%
-8.61M
38.91%
-1.66M
80.71%
-22.03M
1,226.49%
4.77M
121.67%
other non cash items
2.12M
-
4.75M
123.76%
1.34M
71.70%
3.13M
133.13%
-2.64M
184.32%
-22.04M
734.77%
net cash provided by operating activities
-25.15M
-
1.21M
104.82%
-49.62M
4,190.35%
-100.06M
101.68%
-147.18M
47.09%
-224.40M
52.47%
-350.57M
56.23%
investments in property plant and equipment
-1.57M
-
-1.50M
4.83%
-2.59M
72.72%
-2.93M
13.29%
-6.53M
122.57%
-10.82M
65.69%
-7.73M
28.54%
acquisitions net
160K
-
196K
22.50%
231.30M
117,910.20%
135.59M
41.38%
13.30M
90.19%
840.83M
6,222.06%
purchases of investments
-172.27M
-
-544.13M
215.87%
-671.34M
23.38%
-612.77M
8.72%
-1.06B
72.81%
sales maturities of investments
66.69M
-
312.83M
369.09%
535.75M
71.26%
599.47M
11.89%
724.05M
20.78%
other investing activites
6M
-
-231.30M
3,955.00%
-135.59M
41.38%
-13.30M
90.19%
-840.83M
6,222.06%
net cash used for investing activites
-1.57M
-
-1.34M
14.98%
-101.97M
7,515.31%
-234.23M
129.71%
-142.12M
39.33%
-24.12M
83.03%
-342.60M
1,320.63%
debt repayment
common stock issued
74K
-
420K
467.57%
100.03M
23,716.19%
420.07M
319.95%
291.24M
30.67%
298.05M
2.34%
392.39M
31.66%
common stock repurchased
-45K
-
832K
1,948.89%
1.88M
125.36%
1.86M
0.59%
3.32M
77.95%
dividends paid
other financing activites
22.59M
-
60.43M
167.52%
-1.32M
102.19%
1.88M
241.66%
1.06M
43.37%
1.52M
43.27%
833.49M
54,626.92%
net cash used provided by financing activities
22.66M
-
60.85M
168.50%
98.66M
62.14%
422.78M
328.53%
294.18M
30.42%
301.43M
2.47%
1.23B
307.79%
effect of forex changes on cash
-1.29M
-
net change in cash
-4.06M
-
60.72M
1,595.22%
-52.93M
187.16%
88.48M
267.17%
4.88M
94.48%
52.91M
983.88%
534.74M
910.56%
cash at beginning of period
13.14M
-
9.08M
30.91%
69.80M
668.81%
16.87M
75.83%
105.35M
524.38%
110.23M
4.63%
161.41M
46.43%
cash at end of period
9.08M
-
69.80M
668.81%
16.87M
75.83%
105.35M
524.38%
110.23M
4.63%
163.15M
48.00%
696.15M
326.69%
operating cash flow
-25.15M
-
1.21M
104.82%
-49.62M
4,190.35%
-100.06M
101.68%
-147.18M
47.09%
-224.40M
52.47%
-350.57M
56.23%
capital expenditure
-1.57M
-
-1.50M
4.83%
-2.59M
72.72%
-2.93M
13.29%
-6.53M
122.57%
-10.82M
65.69%
-7.73M
28.54%
free cash flow
-26.72M
-
-286K
98.93%
-52.20M
18,153.50%
-103.00M
97.29%
-153.71M
49.24%
-235.22M
53.03%
-358.30M
52.33%

All numbers in USD (except ratios and percentages)